Narrow search
Showing 1 - 10 of 1,227
Cover Image
Global Lessons from the AIDS Pandemic : Economic, Financial, Legal and Political Implications
Condon, Bradly J. (contributor); Sinha, Tapen (contributor) - 2008
This book examines the global HIV/AIDS pandemic from a multidisciplinary perspective, analyzing its economic impact … mechanisms for financing global and national responses. The authors paint a global picture of the HIV/AIDS pandemic one issue … a comprehensive HIV/AIDS strategy. The book analyzes the successes and failures of national governments, international …
Persistent link: https://www.econbiz.de/10013520989
Cover Image
Creating R&D Incentives for Medicines for Neglected Diseases : An Economic Analysis of Parallel Imports, Patents, and Alternative Mechanisms to Stimulate Pharmaceutical Research
Müller-Langer, Frank - 2009
This book is the revised version of a doctoral thesis written at the Graduiertenkolleg Law and Economics at Hamburg University. It addresses the market failure with respect to R&D for medicines for tropical diseases and the lack of access to affordable medicines in poor countries. Tropical...
Persistent link: https://www.econbiz.de/10013521260
Cover Image
AIDS and Aid : A Public Good Approach
Sonntag, Diana - 2010
, affect the well-being of people globally. Of all the health crises originating from the developing world the HIV/AIDS …The Challenge: A Transnational Response to HIV/AIDS -- Profiling the Provision Status of Health-Promoting Public Goods … Against AIDS -- International Transfers -- Regional Constraints and HIV/AIDS -- Summary and Concluding Remarks …
Persistent link: https://www.econbiz.de/10013521335
Cover Image
Making medicines in Africa : the political economy of industrializing for local health
Mackintosh, Maureen (ed.); Banda, Geoffrey (ed.);  … - 2016
, investment and industrial growth in pharmaceuticals to improve access to essential good quality medicines, as part of moving …
Persistent link: https://www.econbiz.de/10012397377
Cover Image
Frugal Innovation in Healthcare : How Targeting Low-Income Markets Leads to Disruptive Innovation
Ramdorai, Aditi - 2015
This book focuses on how companies are innovating with regard to the Bottom-of-the-Pyramid (BOP) − the lowest socio-economic segment, and the organizational conditions they need to be successful. The authors use several examples of disruptive innovations for this market, particularly in the...
Persistent link: https://www.econbiz.de/10012402095
Cover Image
Gesundheits- und Sozialpolitik im Diskurs : Festschrift für Engelbert Theurl zum 60. Geburtstag
Nussbaumer, Josef - 2011
Europa untersucht. Im zweiten Teil werden aus unterschiedlichen Perspektiven Probleme der Gesundheitspolitik erörtert. Der …
Persistent link: https://www.econbiz.de/10014015662
Cover Image
Pharmabetriebslehre
Schöffski, Oliver - 2008 - Zweite, vollständig überarbeitete und erweiterte Auflage
-- Unternehmenszusammenschlüsse und Konzentration -- Preissetzung und Kostenerstattung von Arzneimitteln in Europa -- Arzneimittel-Importe in Europa …
Persistent link: https://www.econbiz.de/10014016236
Cover Image
Causes of Supply Chain Disruptions : An Empirical Analysis in Cold Chains for Food and Pharmaceuticals
Brenner, Verena - 2015
60 supply chain specialists from production, distribution and retail of food and pharmaceuticals, drivers for resilience …
Persistent link: https://www.econbiz.de/10012402017
Cover Image
Pharmalogistik : Prozesse – Instrumente - Praxisbeispiele
Stoller, Christopher W. (ed.) - 2017
Menschen und demographischer Wandel nicht nur Auswirkungen auf die Pharmaindustrie, sondern auch auf die Logistik haben. Trotz …
Persistent link: https://www.econbiz.de/10014017907
Cover Image
Pharma-Einkauf : Qualitätsorientierte Prozesse – Rechtliche Rahmenbedingungen – Trends
Bergmann, Andreas - 2018
an den Einkauf von Fertigarzneimitteln -- Verpackungsmitteleinkauf in der Pharmaindustrie -- Einkauf von CRO …. Zahlreiche Praxisbeispiele zeigen Besonderheiten: die komplexe Struktur des Arzneimittel- und Gesundheitsmarktes entlang der … Auswirkungen auf den Einkauf in der Pharmaindustrie, z. B. Digitalisierung, Telemedizin, personalisierte Medizin, integrierte …
Persistent link: https://www.econbiz.de/10014019602